Drug:
Reaction: DRUG DOSE OMISSION BY DEVICE
20260101 - 20261231
No. 601 - 700
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 601 | 26458188 |
US |
||
Drug dose omission by device, Device delivery system issue, Product packaging quantity issue, Device mechanical issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 602 | 26458230 |
US |
77 | 2 |
Device difficult to use, Drug dose omission by device, Product knowledge deficit, |
||||
EVOLOCUMAB, |
||||
| 603 | 26458372 |
US |
73 | 1 |
Drug dose omission by device, Arthritis, Expired device used, |
||||
ETANERCEPT, |
||||
| 604 | 26458644 |
KR |
11 | 1 |
Drug dose omission by device, Device information output issue, |
||||
SOMATROPIN, |
||||
| 605 | 26458662 |
US |
1 | |
Drug dose omission by device, Device information output issue, Device power source issue, |
||||
SOMATROPIN, |
||||
| 606 | 26458670 |
CO |
2 | |
Device information output issue, Drug dose omission by device, |
||||
SOMATROPIN, |
||||
| 607 | 26459197 |
US |
10 | 1 |
Drug dose omission by device, Device delivery system issue, Device power source issue, |
||||
SOMATROPIN, |
||||
| 608 | 26459208 |
EU |
9 | 2 |
Drug dose omission by device, Device delivery system issue, Product communication issue, |
||||
SOMATROPIN, SOMATROPIN, |
||||
| 609 | 26459212 |
AR |
6 | 1 |
Drug dose omission by device, Device information output issue, Device power source issue, |
||||
SOMATROPIN, |
||||
| 610 | 26459218 |
US |
15 | 1 |
Drug dose omission by device, Device information output issue, |
||||
SOMATROPIN, |
||||
| 611 | 26459223 |
KR |
31 | 1 |
Drug dose omission by device, Device power source issue, |
||||
SOMATROPIN, |
||||
| 612 | 26459422 |
US |
||
Drug dose omission by device, Device delivery system issue, Product quality issue, Product container seal issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 613 | 26459507 |
|||
Psoriatic arthropathy, Post procedural discomfort, Arthralgia, Movement disorder, Drug dose omission by device, Needle issue, Accidental exposure to product, Off label use, Device issue, Drug ineffective, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, OXYCODONE HYDROCHLORIDE, OXYCODONE, DUPILUMAB, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, MONTELUKAST SODIUM, DULOXETINE HYDROCHLORIDE, PHENTERMINE HYDROCHLORIDE, METHIMAZOLE, TOPIRAMATE, FEXOFENADINE HYDROCHLORIDE, |
||||
| 614 | 26459668 |
CO |
14 | 1 |
Drug dose omission by device, Device defective, Device information output issue, Device issue, |
||||
SOMATROPIN, SOMATROPIN, |
||||
| 615 | 26460189 |
US |
2 | |
Accidental exposure to product, Drug dose omission by device, Device malfunction, |
||||
SECUKINUMAB, |
||||
| 616 | 26460223 |
US |
||
Drug dose omission by device, No adverse event, |
||||
GLUCAGON, |
||||
| 617 | 26452901 |
US |
||
Drug dose omission by device, Device delivery system issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 618 | 26452985 |
US |
44 | 2 |
Drug dose omission by device, Pain, |
||||
ADALIMUMAB-ATTO, |
||||
| 619 | 26452999 |
US |
||
Illness, Drug dose omission by device, Device delivery system issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, BUDESONIDE, |
||||
| 620 | 26453251 |
US |
60 | 1 |
Lung neoplasm malignant, Cardiac disorder, Road traffic accident, Device difficult to use, Drug dose omission by device, |
||||
EVOLOCUMAB, |
||||
| 621 | 26453485 |
BR |
59 | 2 |
Frustration tolerance decreased, General physical health deterioration, Device malfunction, Device failure, Drug dose omission by device, Hyperphagia, Off label use, Wrong technique in product usage process, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, |
||||
| 622 | 26453657 |
US |
59 | 2 |
Pain in extremity, Drug dose omission by device, |
||||
ETANERCEPT, HYDROXYCHLOROQUINE SULFATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 623 | 26453670 |
US |
2 | |
Cardiac disorder, Gastrointestinal disorder, Drooling, Lung disorder, Aerophagia, Nervousness, Sleep disorder, Anal incontinence, Sputum discoloured, Nausea, Diarrhoea, Headache, Asthenia, Feeling abnormal, Cough, Drug dose omission by device, Accidental underdose, Device leakage, |
||||
AMIKACIN, AMIKACIN, ALPRAZOLAM, ALBUTEROL SULFATE, ALBUTEROL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, RIZATRIPTAN BENZOATE, MELATONIN, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, RABEPRAZOLE, RANOLAZINE, TIZANIDINE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, ERGOCALCIFEROL, RIFAMPIN, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, |
||||
| 624 | 26453790 |
US |
2 | |
Accidental exposure to product, Drug dose omission by device, Wrong technique in product usage process, Device malfunction, |
||||
SECUKINUMAB, |
||||
| 625 | 26453793 |
US |
||
Drug dose omission by device, Device delivery system issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 626 | 26453799 |
US |
||
Drug dose omission by device, Device delivery system issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, PREDNISONE, |
||||
| 627 | 26454431 |
US |
1 | |
Hypoacusis, Drug dose omission by device, Device difficult to use, |
||||
EVOLOCUMAB, |
||||
| 628 | 26454580 |
US |
58 | 2 |
Device malfunction, Device issue, Drug dose omission by device, |
||||
OFATUMUMAB, |
||||
| 629 | 26454776 |
EU |
||
Drug dose omission by device, Device defective, |
||||
| 630 | 26454777 |
EU |
2 | |
Drug dose omission by device, Device mechanical issue, |
||||
SOMATROPIN, |
||||
| 631 | 26455013 |
US |
35 | |
Panic attack, Dyspnoea, Drug dose omission by device, Wrong technique in product usage process, Device delivery system issue, Wrong technique in device usage process, |
||||
ALBUTEROL SULFATE, |
||||
| 632 | 26455197 |
CO |
1 | |
Drug dose omission by device, Device information output issue, |
||||
SOMATROPIN, |
||||
| 633 | 26455207 |
CL |
11 | 2 |
Drug dose omission by device, Device information output issue, Device power source issue, |
||||
SOMATROPIN, |
||||
| 634 | 26455627 |
US |
83 | 2 |
Diverticulitis, Colitis, Bronchitis, Wrong technique in product usage process, Injury associated with device, Dry skin, Eczema, Drug dose omission by device, Product communication issue, Device difficult to use, Injection site irritation, Injection site pruritus, Injection site pain, Injection site swelling, |
||||
EVOLOCUMAB, EVOLOCUMAB, |
||||
| 635 | 26455739 |
US |
1 | |
Accidental exposure to product, Device malfunction, Device delivery system issue, Drug dose omission by device, Exposure via skin contact, |
||||
SECUKINUMAB, |
||||
| 636 | 26455865 |
US |
1 | |
Device defective, Accidental exposure to product, Device delivery system issue, Device leakage, Drug dose omission by device, Condition aggravated, |
||||
SECUKINUMAB, |
||||
| 637 | 26456094 |
US |
87 | 2 |
Injection site pain, Product communication issue, Fear of injection, Device difficult to use, Drug dose omission by device, Injection site erythema, |
||||
EVOLOCUMAB, EVOLOCUMAB, CLOPIDOGREL, |
||||
| 638 | 26456360 |
US |
2 | |
Device deployment issue, Device delivery system issue, Drug dose omission by device, |
||||
PEGINTERFERON BETA-1A, |
||||
| 639 | 26456506 |
US |
1 | |
Device malfunction, Device leakage, Accidental exposure to product, Drug dose omission by device, |
||||
SECUKINUMAB, |
||||
| 640 | 26456539 |
US |
30 | 1 |
Device malfunction, Needle issue, Injection site haemorrhage, Device leakage, Drug dose omission by device, |
||||
OFATUMUMAB, |
||||
| 641 | 26456738 |
US |
||
Drug dose omission by device, Product quality issue, Device delivery system issue, Incorrect dose administered by device, Off label use, |
||||
ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 642 | 26448383 |
US |
69 | 2 |
Device difficult to use, Drug dose omission by device, Product communication issue, Illness, Cough, Injection site bruising, |
||||
EVOLOCUMAB, |
||||
| 643 | 26449599 |
US |
||
Pneumonia, Drug dose omission by device, Device delivery system issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 644 | 26449949 |
US |
66 | |
Dyspnoea, Drug dose omission by device, Wrong technique in product usage process, Device deposit issue, Expired device used, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 645 | 26450567 |
US |
2 | |
Sinusitis, Accidental exposure to product, Device use error, Drug dose omission by device, Device difficult to use, Product communication issue, Injection site erythema, Injection site haemorrhage, |
||||
EVOLOCUMAB, EVOLOCUMAB, |
||||
| 646 | 26451007 |
US |
11 | 2 |
Drug dose omission by device, Device information output issue, |
||||
SOMATROPIN, |
||||
| 647 | 26451302 |
US |
||
Drug dose omission by device, Device delivery system issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 648 | 26451303 |
US |
||
Drug dose omission by device, Device delivery system issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 649 | 26451612 |
US |
86 | 1 |
Bladder cancer, Product communication issue, Device difficult to use, Drug dose omission by device, Confusional state, |
||||
EVOLOCUMAB, EVOLOCUMAB, EVOLOCUMAB, EVOLOCUMAB, EVOLOCUMAB, INSULIN GLARGINE, INSULIN GLARGINE, DULAGLUTIDE, INSULIN ASPART, |
||||
| 650 | 26452202 |
US |
2 | |
Accidental exposure to product, Drug dose omission by device, Device leakage, |
||||
OFATUMUMAB, |
||||
| 651 | 26452267 |
US |
25 | 2 |
Device malfunction, Injection site erythema, Device leakage, Drug dose omission by device, Accidental exposure to product, |
||||
SECUKINUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, |
||||
| 652 | 26452299 |
CL |
11 | 2 |
Drug dose omission by device, Device information output issue, Device power source issue, |
||||
SOMATROPIN, |
||||
| 653 | 26452304 |
KR |
9 | 1 |
Device breakage, Device material issue, Drug dose omission by device, |
||||
SOMATROPIN, |
||||
| 654 | 26452305 |
GB |
14 | 1 |
Drug dose omission by device, Device information output issue, |
||||
SOMATROPIN, |
||||
| 655 | 26452319 |
CO |
12 | 2 |
Drug dose omission by device, Device leakage, Device mechanical issue, |
||||
SOMATROPIN, |
||||
| 656 | 26452320 |
KR |
13 | 1 |
Drug dose omission by device, Device power source issue, Device information output issue, |
||||
SOMATROPIN, |
||||
| 657 | 26452495 |
US |
50 | 2 |
Injection site pain, Drug dose omission by device, |
||||
TERIPARATIDE, TERIPARATIDE, TERIPARATIDE, TERIPARATIDE, TERIPARATIDE, TERIPARATIDE, |
||||
| 658 | 26452499 |
US |
47 | 2 |
Wrong technique in product usage process, Device difficult to use, Drug dose omission by device, Blood glucose increased, Headache, Product communication issue, |
||||
EVOLOCUMAB, EVOLOCUMAB, PREDNISONE, AMOXICILLIN, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, EZETIMIBE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, GABAPENTIN, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, HYDROCHLOROTHIAZIDE, LANSOPRAZOLE, LUBIPROSTONE, MECLIZINE HCL 12.5 MG, MECLIZINE HCL 25 MG, MECLIZINE HYDROCHLORIDE, MECLIZINE, MECLIZINE HCL 25MG, MECLIZINE HCL 12.5MG, GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE, PROGESTERONE, ROSUVASTATIN, ALBUTEROL SULFATE, ERGOCALCIFEROL, |
||||
| 659 | 26452614 |
US |
50 | 2 |
Scratch, Injection site pain, Drug dose omission by device, |
||||
GALCANEZUMAB-GNLM, |
||||
| 660 | 26446321 |
US |
2 | |
Device issue, Accidental exposure to product, Drug dose omission by device, |
||||
SECUKINUMAB, |
||||
| 661 | 26447100 |
US |
55 | |
Asthma, Drug dose omission by device, Wrong technique in product usage process, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 662 | 26447799 |
US |
69 | 2 |
Drug dose omission by device, Device difficult to use, Headache, Accidental exposure to product, |
||||
ERENUMAB-AOOE, LORAZEPAM, |
||||
| 663 | 26448064 |
US |
15 | 2 |
Mental disorder, Migraine, Accidental exposure to product, Neurological symptom, Drug dose omission by device, |
||||
FREMANEZUMAB-VFRM, |
||||
| 664 | 26448180 |
US |
27 | 2 |
Drug dose omission by device, Injection site pain, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, |
||||
| 665 | 26441253 |
US |
||
Drug dose omission by device, Device delivery system issue, Device mechanical issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 666 | 26441432 |
US |
57 | 2 |
Nasal congestion, Product cleaning inadequate, Device defective, Sinusitis, Drug dose omission by device, |
||||
BECLOMETHASONE DIPROPIONATE, |
||||
| 667 | 26442030 |
US |
58 | 2 |
Hypoacusis, Pain in extremity, Wrong technique in product usage process, Device difficult to use, Feeling abnormal, Drug dose omission by device, Multiple use of single-use product, |
||||
ETANERCEPT, |
||||
| 668 | 26442709 |
US |
||
Adverse event, Drug dose omission by device, Device delivery system issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 669 | 26442886 |
US |
||
Dyspnoea, Illness, Drug dose omission by device, Device delivery system issue, Device malfunction, Off label use, |
||||
ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 670 | 26442887 |
US |
||
Drug dose omission by device, Device delivery system issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 671 | 26442989 |
US |
67 | 1 |
Injection site pain, Drug dose omission by device, Condition aggravated, |
||||
ETANERCEPT, |
||||
| 672 | 26443147 |
GB |
||
Faecaloma, Product leakage, Influenza, Nasopharyngitis, Drug dose omission by device, Product dose omission issue, Product use issue, Product prescribing issue, Intentional dose omission, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 673 | 26443296 |
US |
||
Device defective, Product dose omission issue, Product physical issue, Device deployment issue, Device delivery system issue, Drug dose omission by device, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, ROMIPLOSTIM, ERENUMAB-AOOE, |
||||
| 674 | 26443947 |
US |
2 | |
Thoracic vertebral fracture, Thoracic vertebral fracture, Cellulitis, Road traffic accident, Loss of consciousness, Rib fracture, Skin laceration, Mobility decreased, Pain, Muscle atrophy, Dysstasia, Contusion, Product dose omission issue, Suspected product contamination, Drug dose omission by device, Needle issue, Device leakage, Product administered at inappropriate site, |
||||
ABALOPARATIDE, LEVOTHYROXINE SODIUM, AMLODIPINE BESYLATE, METOPROLOL TARTRATE, METOPROLOL, |
||||
| 675 | 26445603 |
CO |
1 | |
Drug dose omission by device, Device information output issue, |
||||
SOMATROPIN, |
||||
| 676 | 26436400 |
US |
28 | 1 |
Device malfunction, Drug dose omission by device, Device leakage, Accidental exposure to product, |
||||
OFATUMUMAB, ACETAMINOPHEN, DEXTROMETHORPHAN HBR, ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL, |
||||
| 677 | 26436937 |
US |
36 | 2 |
Device difficult to use, Device use error, Accidental exposure to product, Drug dose omission by device, Headache, |
||||
ERENUMAB-AOOE, |
||||
| 678 | 26437035 |
US |
||
Drug dose omission by device, Device delivery system issue, Product substitution issue, Drug ineffective, |
||||
ALBUTEROL SULFATE, ALBUTEROL, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, FAMOTIDINE, ALPRAZOLAM, |
||||
| 679 | 26437121 |
US |
2 | |
Drug dose omission by device, |
||||
| 680 | 26437550 |
US |
||
Drug dose omission by device, Device delivery system issue, Device issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 681 | 26437554 |
US |
||
Drug dose omission by device, Device delivery system issue, Device mechanical issue, Off label use, |
||||
ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 682 | 26437709 |
US |
79 | 2 |
Device difficult to use, Frustration tolerance decreased, Blood pressure increased, Drug dose omission by device, Product communication issue, |
||||
EVOLOCUMAB, EVOLOCUMAB, EVOLOCUMAB, SEMAGLUTIDE, ORAL SEMAGLUTIDE, TIRZEPATIDE, |
||||
| 683 | 26440371 |
PR |
11 | 1 |
Drug dose omission by device, Device defective, Device use error, |
||||
SOMATROPIN, |
||||
| 684 | 26440374 |
US |
44 | 2 |
Drug dose omission by device, Needle issue, |
||||
SOMATROPIN, |
||||
| 685 | 26440386 |
US |
11 | 2 |
Drug dose omission by device, Device information output issue, |
||||
SOMATROPIN, |
||||
| 686 | 26440420 |
GB |
2 | |
Hemihypoaesthesia, Hypotension, Dizziness, Brain fog, Heart rate irregular, Vomiting, Fatigue, Asthenia, Nausea, Drug dose omission by device, Device mechanical issue, Arthralgia, |
||||
GLATIRAMER ACETATE, GLATIRAMER ACETATE INJECTION, GLATIRAMER, GLATIRAMER ACETATE, GLATIRAMER ACETATE INJECTION, GLATIRAMER, GLATIRAMER ACETATE, GLATIRAMER ACETATE INJECTION, GLATIRAMER, GLATIRAMER ACETATE, GLATIRAMER ACETATE INJECTION, GLATIRAMER, |
||||
| 687 | 26440552 |
US |
1 | |
Oxygen saturation abnormal, Blood pressure increased, Blood glucose increased, Drug dose omission by device, Wrong technique in product usage process, |
||||
INSULIN DEGLUDEC, |
||||
| 688 | 26440610 |
US |
8 | 2 |
Drug dose omission by device, Wrong technique in device usage process, Device leakage, Device issue, |
||||
SOMATROPIN, |
||||
| 689 | 26440613 |
US |
23 | 1 |
Drug dose omission by device, Device defective, |
||||
SOMATROPIN, HYDROCORTISONE, LEVOTHYROXINE SODIUM, TESTOSTERONE, LEVETIRACETAM, |
||||
| 690 | 26440734 |
CO |
2 | |
Drug dose omission by device, Device use issue, Device mechanical issue, |
||||
SOMATROPIN, |
||||
| 691 | 26431117 |
US |
64 | 2 |
Needle issue, Device leakage, Accidental exposure to product, Drug dose omission by device, |
||||
OFATUMUMAB, |
||||
| 692 | 26431300 |
US |
||
Drug dose omission by device, Device delivery system issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 693 | 26431302 |
US |
||
Drug dose omission by device, Device delivery system issue, Device occlusion, |
||||
ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 694 | 26431305 |
US |
||
Drug dose omission by device, Device delivery system issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 695 | 26431660 |
US |
1 | |
On and off phenomenon, Dyskinesia, Liquid product physical issue, Drug dose omission by device, |
||||
APOMORPHINE HYDROCHLORIDE, |
||||
| 696 | 26431752 |
US |
41 | 2 |
Trigger points, Drug dose omission by device, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, |
||||
| 697 | 26432062 |
US |
||
Drug dose omission by device, Device delivery system issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 698 | 26432063 |
US |
||
Drug dose omission by device, Device delivery system issue, Product packaging quantity issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 699 | 26432252 |
US |
||
Drug dose omission by device, Product knowledge deficit, Device delivery system issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 700 | 26432254 |
US |
||
Drug dose omission by device, Device delivery system issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28